Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

Abstract

BACKGROUND In view of evidence that statin therapy increases risk of diabetes, the balance of benefit and risk of these drugs in primary prevention has become controversial. We undertook an analysis of participants from the JUPITER trial to address the balance of vascular benefits and diabetes hazard of statin use. METHODS In the randomised, double-blind… (More)
DOI: 10.1016/S0140-6736(12)61190-8

Topics

Cite this paper

@article{Ridker2012CardiovascularBA, title={Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.}, author={Paul M. Ridker and A. Pradhan and Jean G Macfadyen and Peter Libby and Robert J Glynn}, journal={Lancet}, year={2012}, volume={380 9841}, pages={565-71} }